AMEX:TOVX

Theriva Biologics, Inc.

Stock

USD

Last Close

0.27

26/07 19:58

Market Cap

4.72M

Beta: 1.59

Volume Today

48.14K

Avg: 39.97K

PE Ratio

−0.45

PFCF: −0.45

Overview Financials Filings people Ownership API Chart Data

locale
United States
market
STOCKS
website
www.therivabio.com

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically admin...Show More

peer of

Earnings

Earnings Release in 10 days

Earnings per Share (Estimate*)

Revenue (Estimate*)

*Estimate based on analyst consensus